Sanctuary Advisors LLC bought a new position in shares of CVS Health Corporation (NYSE:CVS - Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 181,430 shares of the pharmacy operator's stock, valued at approximately $18,769,000.
A number of other large investors also recently bought and sold shares of CVS. Elevation Wealth Partners LLC boosted its stake in shares of CVS Health by 41.8% during the 2nd quarter. Elevation Wealth Partners LLC now owns 356 shares of the pharmacy operator's stock worth $37,000 after acquiring an additional 105 shares in the last quarter. Apella Capital LLC raised its holdings in CVS Health by 1.7% in the 2nd quarter. Apella Capital LLC now owns 6,940 shares of the pharmacy operator's stock worth $724,000 after purchasing an additional 117 shares during the period. CYBER HORNET ETFs LLC boosted its position in CVS Health by 4.1% during the third quarter. CYBER HORNET ETFs LLC now owns 3,442 shares of the pharmacy operator's stock worth $259,000 after purchasing an additional 134 shares in the last quarter. Northwestern Mutual Investment Management Company LLC grew its holdings in CVS Health by 0.3% in the fourth quarter. Northwestern Mutual Investment Management Company LLC now owns 40,560 shares of the pharmacy operator's stock valued at $3,219,000 after purchasing an additional 136 shares during the period. Finally, CoreCap Advisors LLC increased its position in shares of CVS Health by 4.2% in the second quarter. CoreCap Advisors LLC now owns 3,481 shares of the pharmacy operator's stock valued at $360,000 after buying an additional 139 shares in the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of equities analysts have weighed in on the stock. Deutsche Bank Aktiengesellschaft upped their price objective on shares of CVS Health from $88.00 to $92.00 and gave the stock a "buy" rating in a research report on Thursday, May 7th. Argus upped their price target on shares of CVS Health from $104.00 to $114.00 and gave the stock a "buy" rating in a research report on Wednesday, August 19th. Wall Street Zen raised shares of CVS Health from a "buy" rating to a "strong-buy" rating in a research note on Saturday, August 8th. Truist Financial boosted their price objective on CVS Health from $108.00 to $118.00 and gave the stock a "buy" rating in a research note on Tuesday, July 14th. Finally, Piper Sandler reaffirmed an "overweight" rating and issued a $113.00 price target on shares of CVS Health in a research note on Monday, June 1st. Twenty-two investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $107.17.
Check Out Our Latest Analysis on CVS
CVS Health Stock Performance
Shares of CVS stock opened at $93.01 on Monday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.66 and a current ratio of 0.87. The firm has a market cap of $118.96 billion, a P/E ratio of 24.61, a P/E/G ratio of 0.85 and a beta of 0.61. The firm's 50 day moving average price is $102.02 and its 200-day moving average price is $88.95. CVS Health Corporation has a one year low of $69.51 and a one year high of $110.68.
CVS Health (NYSE:CVS - Get Free Report) last announced its earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.87 by $0.71. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.The company had revenue of $106.10 billion for the quarter, compared to analyst estimates of $100.03 billion. During the same quarter in the previous year, the company earned $1.81 earnings per share. The firm's quarterly revenue was up 7.3% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. As a group, equities research analysts predict that CVS Health Corporation will post 8.02 EPS for the current year.
CVS Health Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Monday, August 3rd. Investors of record on Thursday, July 23rd were issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 2.9%. The ex-dividend date was Thursday, July 23rd. CVS Health's dividend payout ratio (DPR) is 70.37%.
About CVS Health
(
Free Report)
CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.
Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider CVS Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.
While CVS Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.
"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
